Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Viridian Therapeutics (VRDN)
NASDAQ:VRDN
Holding VRDN?
Track your performance easily
See the Price Targets and Ratings of:
VRDN Analyst Ratings
Strong Buy
14 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
VRDN Stock 12 Month Forecast
Average Price Target
$40.67
▲(101.94% Upside)
| Highest Price Target$61.00 | Average Price Target$40.67 | Lowest Price Target$22.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
Reiterated
11/13/24
Goldman Sachs
Reiterated
11/13/24
Jefferies
Assigned
11/13/24
Leerink Partners
Reiterated
11/12/24
LifeSci Capital
Reiterated
11/12/24
RBC Capital
Reiterated
11/12/24
BTIG
Reiterated
11/12/24
Wedbush
Reiterated
11/12/24
Stifel Nicolaus
Reiterated
11/12/24
Needham
Reiterated
11/12/24
JMP Securities
$38→$40
Buy
98.61%
Upside
Reiterated
11/12/24
Viridian Therapeutics Earns Buy Rating on Promising Trial Results and Strong Financial Position
B.Riley Financial
$20→$22
Hold
9.24%
Upside
Reiterated
09/11/24
Viridian Therapeutic (VRDN) PT Raised to $22 at B.RileyB.Riley analyst Kalpit Patel raised the price target on Viridian Therapeutic (NASDAQ: VRDN) to $22.00 (from $20.00) while maintaining a Neutral rating.
Oppenheimer
$28
Buy
39.03%
Upside
Reiterated
09/11/24
Oppenheimer Reaffirms Their Buy Rating on Viridian Therapeutics (VRDN)
Wells Fargo
$37
Buy
83.71%
Upside
Reiterated
09/10/24
Buy Rating for Viridian Therapeutics Backed by Promising Veligrotug Phase 3 Results and Favorable Safety Profile
Ladenburg Thalmann & Co.
―
Hold
―
Reiterated
08/09/24
Ladenburg Thalmann & Co. Remains a Hold on Viridian Therapeutics (VRDN)
Best Analysts Covering Viridian Therapeutics
Which Analyst Should I Follow If I Want to Buy VRDN and Sell After:
1 Month
xxx
Success Rate
13/24 ratings generated profit
Average Return
+7.15%
reiterated a xxx
rating 11 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 54.17% of your transactions generating a profit, with an average return of +7.15% per trade.
3 Months
xxx
Success Rate
13/22 ratings generated profit
Average Return
+6.25%
reiterated a xxx
rating 11 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 59.09% of your transactions generating a profit, with an average return of +6.25% per trade.
1 Year
Success Rate
23/36 ratings generated profit
Average Return
+11.66%
reiterated a buy rating 11 days ago
Copying Laura Chico's trades and holding each position for 1 Year would result in 63.89% of your transactions generating a profit, with an average return of +11.66% per trade.
2 Years
xxx
Success Rate
17/24 ratings generated profit
Average Return
+15.78%
reiterated a xxx
rating 11 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 70.83% of your transactions generating a profit, with an average return of +15.78% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
VRDN Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
28
32
36
32
30
Buy
2
2
4
4
4
Hold
3
2
2
2
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
33
36
42
38
35
Each month's total comprises the sum of three months' worth of ratings.
VRDN Financial Forecast
VRDN Stock Forecast FAQ
What is VRDN’s average 12-month price target, according to analysts?
Based on analyst ratings, Viridian Therapeutics’s 12-month average price target is $40.67.
What is VRDN’s upside potential, based on the analysts’ average price target?
Viridian Therapeutics has 101.94% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is VRDN a Buy, Sell or Hold?
Viridian Therapeutics has a consensus rating of Strong Buy which is based on 14 buy ratings, 1 hold ratings and 0 sell ratings.
What is Viridian Therapeutics’s price target?
The average price target for Viridian Therapeutics is $40.67. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $61.00 ,the lowest forecast is $22.00. The average price target represents 101.94% Increase from the current price of $20.14.
The highest analyst price target is $61.00 ,the lowest forecast is $22.00. The average price target represents 101.94% Increase from the current price of $20.14.
What do analysts say about Viridian Therapeutics?
Viridian Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Streets Analysts.
How can I buy shares of VRDN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.